Company Sector

Gastroenterology

Gastroenterology includes companies targeting digestive system disorders such as inflammatory bowel disease, motility disorders, liver-adjacent GI disease, and other gastrointestinal conditions. This page brings together names with direct exposure to GI-focused pipelines or products.

Why watch Gastroenterology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Gastroenterology news

The latest feed items from companies currently grouped under Gastroenterology.

01
2026-08-07 20:05 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
02
2026-08-04 20:02 EST
SYRESpyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Source: Spyre Therapeutics, Inc.
03
2026-07-02 20:05 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
04
2026-06-15 12:00 EST
SYRESpyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Source: Spyre Therapeutics, Inc.
05
2026-06-05 20:01 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
06
2026-06-03 12:00 EST
SYRESpyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
Source: Spyre Therapeutics, Inc.
07
2026-05-26 20:10 EST
SYRESpyre Therapeutics to Participate in Upcoming June Investor Conferences
Source: Spyre Therapeutics, Inc.
08
2026-05-05 12:00 EST
SYRESpyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Spyre Therapeutics, Inc.
09
2026-05-01 20:28 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
10
2026-04-16 20:15 EST
SYRESpyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Source: Spyre Therapeutics, Inc.
11
2026-04-15 02:38 EST
SYRESpyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock
Source: Spyre Therapeutics, Inc.
12
2026-04-13 20:46 EST
SYRESpyre Therapeutics Announces Proposed Public Offering of its Common Stock
Source: Spyre Therapeutics, Inc.
13
2026-04-13 11:00 EST
SYRESpyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Source: Spyre Therapeutics, Inc.
14
2026-04-10 20:05 EST
SYRESpyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
Source: Spyre Therapeutics, Inc.
15
2026-04-03 20:01 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
16
2026-03-16 12:00 EST
SYRESpyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
Source: Spyre Therapeutics, Inc.
17
2026-03-06 21:05 EST
SYRESpyre Therapeutics Announces Grants of Inducement Awards
Source: Spyre Therapeutics, Inc.
18
2026-02-24 21:05 EST
SYRESpyre Therapeutics to Participate in Upcoming March Investor Conferences
Source: Spyre Therapeutics, Inc.
19
2026-02-19 21:02 EST
SYRESpyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Source: Spyre Therapeutics, Inc.
20
2026-02-18 13:00 EST
SYRESpyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Source: Spyre Therapeutics, Inc.

View all latest news

Companies in Gastroenterology

2 companies tagged with Gastroenterology.

MORF

Morphic Holding, Inc.

SYRE

Spyre Therapeutics, Inc.

Frequently Asked Questions

What does the Gastroenterology sector include?

How many companies are currently tagged with Gastroenterology?

2 companies are currently grouped under Gastroenterology on BioPharmSignal.

Which companies are most visible in the Gastroenterology group right now?

MORF, SYRE are among the companies currently shown on this sector page.

How can I watch news for Gastroenterology?

Use the Watch button on this page to subscribe to Gastroenterology headlines and related company updates through your BioPharmSignal saved filters.

What kinds of updates usually appear for Gastroenterology?

The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Gastroenterology.